Press releases and news

Notice to attend the Annual General Meeting of BioGaia AB (publ)

BioGaia AB (publ) (the “Company”) will hold its Annual General Meeting at 4 p.m. on 7 May 2026, at Klara Konferens & Happynings på Klara Strand, Klarabergsviadukten 90, in Stockholm. The doors will be opened for registration at 3:30 p.m. Right to participate In order to participate in the Annual General Meeting (AGM), shareholders must […]

BioGaia Annual and Sustainability Report 2025 published

The BioGaia (NASDAQ: BIOG) Annual and Sustainability Report 2025, including Corporate Governance Report 2025, and the Remuneration Report 2025 in Swedish as well as an English translation are now available to download from the BioGaia website: https://www.biogaiagroup.com/investors/reports-and-presentations/annual-reports The Swedish Annual and Sustainability Report 2025 is also available on BioGaia’s website in European Single Electronic Format […]

10-year follow-up study shows infant probiotics are positively associated with a reduction of childhood functional abdominal pain

We are proud to announce the publication of a 10-year follow-up study of our probiotic strain, Limosilactobacillus reuteri (L. reuteri) ProtectisÒ also known as L. reuteri DSM 17938, in the peer-reviewed journal Nutrients. The study shows that early supplementation with this strain during the first three months of life is associated with a markedly lower […]

BioGaia exercises option to acquire remaining shares in Nutraceutics

BioGaia exercises the option to acquire the remaining 20 percent of the shares in Nutraceutics, the parent company to BioGaia’s exclusive distributor of BioGaia’s own products in the USA. BioGaia AB (publ) ("BioGaia") announced on December 30, 2021 that BioGaia, through its American subsidiary BioGaia Biologics Inc, had entered into an agreement to acquire all […]

BioGaia AB extends long-standing distribution partnership with Ewopharma

BioGaia AB (NASDAQ: BIOG) has signed a renewed distribution agreement with Ewopharma. The extended agreement reinforces the companies’ successful collaboration to date and reflects a shared ambition to further accelerate growth across the European region. Ewopharma is a pharmaceutical marketing organization and commercialization partner active in Central Eastern Europe and Switzerland, with expertise spanning prescription […]

BioGaia AB: Year-end report January – December 2025

FOURTH QUARTER 2025 (Figures in parentheses refer to the corresponding period last year, unless otherwise specified.) Net sales amounted to SEK 440.6 million (364.8), an increase of SEK 75.7 million, an organic sales increase of 32% (21% including foreign exchange effects). Net sales in the Pediatrics segment amounted to SEK 331.5 million (270.3), an organic […]

BioGaia’s results for the fourth quarter to exceed market expectations

(Figures in the brackets refer to the same period the previous year) During the fourth quarter of 2025, BioGaia’s sales were positively affected by quarterly variations for individual orders of approximately SEK 35 million. For the fourth quarter, sales are preliminarily estimated at SEK 441 million (365), an increase of 21% (excluding foreign exchange effects, […]

Invitation to media and analyst briefing for BioGaia Q4 2025 report

BioGaia’s (NASDAQ: BIOG) financial report for the fourth quarter of 2025 will be published at approximately 8:00 AM CET on February 12, 2026. The company will issue a press release with the complete financial report attached, including tables. Following publication of the press release, the financial report will be available on BioGaia´s website. CEO Theresa […]

BioGaia wishes you a Merry Christmas and a Healthy and Happy New Year!